BioSpace News Archive

Pharm Country

Janssen’s Save Legs. Change Lives.™ is Creating a More Equitable Future for Communities at Risk of PAD-Related Amputations

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the first impact summary for its Save Legs.

November 4, 2022
·
11 min read
Drug Development

Asher Bio Presents New Data Demonstrating Preclinical Proof-of-Concept for AB359, a Highly Selective CD8-Targeted IL-2 Therapy, for Chronic Hepatitis B (HBV) at AASLD 2022

Asher Biotherapeutics, Inc. today announced new preclinical data demonstrating proof-of-concept for AB359 as a novel immunotherapy approach for chronic HBV. AB359 is Asher Bio’s CD8-targeted interleukin-2 (IL-2) immunotherapy for the treatment of chronic viral infection.

November 4, 2022
·
4 min read
Business

Applied UV to Host Third Quarter 2022 Conference Call on November 15, 2022

Applied UV, Inc. announced that the Company will be hosting an investor conference call and live webcast on Tuesday, November 15, 2022 at 9:00 am ET.

November 4, 2022
·
4 min read
Revance Announces Two Publications in The Aesthetic Surgery Journal That Advance Glabellar Line Injection Technique and Assessment

Revance Therapeutics, Inc. today announced the publication of two peer-reviewed articles in the Aesthetic Surgery Journal, the official journal of The Aesthetic Society.

November 4, 2022
·
11 min read
Biotech Bay

Cerus Corporation to Participate in Upcoming November 2022 Investor Conferences

Cerus Corporation announced that Vivek Jayaraman, Cerus’ chief operating officer, is scheduled to participate in two conferences.

November 4, 2022
·
1 min read
BioForest

Chinook Therapeutics Presents Updated Data from BION-1301 Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) and CHK-336 Preclinical Efficacy Data at the American Society of Nephrology (ASN) Kidney Week 2022

Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced two posters on the BION-1301 and CHK-336 programs being presented today at ASN Kidney Week 2022 being held virtually and live in Orlando, Florida.

November 4, 2022
·
13 min read
Policy

Waterdrop Launches Insurance against Breast Cancer Recurrence

The National Cancer Institute’s SEER statistics show that breast cancer recurrence rate is as much as 30%.

November 4, 2022
·
3 min read
Global Digital Therapeutics Market Size & Share to Surpass $14.52 Bn by 2028 | Vantage Market Research

Vantage Market Research analyses that the Digital Therapeutics Market which was USD 3.16 Billion in 2021, would rocket up to USD 14.52 Billion by 2028, and is expected to undergo a CAGR of 28.1% during the forecast period 2022 to 2028.

November 4, 2022
·
7 min read
Biotech Bay

California Life Sciences announces 19th annual Pantheon Award Winners

California Life Sciences, the state’s most impactful life sciences trade association, announced the winners of its 19th annual Pantheon Awards.

November 4, 2022
·
2 min read
Drug Development

Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022

Regulatory News: Innate Pharma SA announced that the following presentations will be presented at the 64th ASH Annual Meeting taking place from December 10-13, 2022, in New Orleans, Louisiana.

November 4, 2022
·
6 min read